We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current DRRX market cap is 29.05M. The company's latest EPS is USD -0.8899 and P/E is -1.08.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.08M | 1.74M | 2.67M | 1.83M | 2.17M |
Operating Income | -10.05M | -9.56M | -6.25M | -5.72M | -3.4M |
Net Income | -11.18M | -3.02M | -1.44M | -7.64M | -3.7M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 29.56M | 30.11M | 13.98M | 19.28M | 8.55M |
Operating Income | -19.15M | -12.62M | -34.27M | -35.08M | -36.88M |
Net Income | -20.58M | -582k | -36.27M | -35.33M | -27.62M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 48.66M | 54.73M | 45.19M | 36.22M | 29.85M |
Total Liabilities | 43.16M | 40.32M | 30.41M | 27.92M | 24.82M |
Total Equity | 5.5M | 14.41M | 14.78M | 8.3M | 5.04M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 86.02M | 75.64M | 91.99M | 60.1M | 45.19M |
Total Liabilities | 63.16M | 35.53M | 34.21M | 35.12M | 30.41M |
Total Equity | 22.86M | 40.12M | 57.78M | 24.99M | 14.78M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -18.61M | -26.09M | -34.41M | -6.77M | -10.43M |
Investing | -3.08M | -132k | -1.17M | -887k | 1.31M |
Financing | 9.97M | 21.72M | 20.5M | -1.5M | -3.64M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 11.1M | -38.7M | -37.31M | -26.28M | -34.41M |
Investing | -27.32M | 9.43M | 15.31M | 19.84M | -1.17M |
Financing | 19.5M | 15.66M | 50.53M | 83k | 20.5M |
Market Cap | 29.05M |
Price to Earnings Ratio | -1.08 |
Price to Sales Ratio | 3.49 |
Price to Cash Ratio | 1.05 |
Price to Book Ratio | 2.02 |
Dividend Yield | - |
Shares Outstanding | 31.04M |
Average Volume (1 week) | 133.79k |
Average Volume (1 Month) | 93.58k |
52 Week Change | 45.64% |
52 Week High | 1.88 |
52 Week Low | 0.481 |
Spread (Intraday) | 0.09 (8.63%) |
Company Name | Durect Corp |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.durect.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions